Crossmark

Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection

Published Online: 2019-08-22

Published Print: 2020-02

Authors

Feuerstadt, Paul https://orcid.org/0000-0002-7643-9576
Hong, Simon J.

Brandt, Lawrence J.
License Information

Text and Data Mining valid from 2019-08-22

Version of Record valid from 2019-08-22
More Information

Article History

Received: 1 April 2019

Accepted: 12 August 2019

First Online: 22 August 2019

Compliance with Ethical Standards

:

: Feuerstadt serves as a Speakers bureau for Merck and Co., and Consultant for Ferring Pharmaceutical, Roche Diagnostics. Hong and Brandt report no disclosure.

Document is current